InvestorsHub Logo
Followers 62
Posts 7548
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Monday, 01/09/2023 4:47:25 PM

Monday, January 09, 2023 4:47:25 PM

Post# of 425892
The retail price of Vascepa, without coupons or insurance, is over $100 for a 30 day supply...The cost to Amarin for a 30 day bottle is less than half of that figure...This leaves room for Amarin(or a BP) to lower the retail cost for Vascepa, while Vascepa would still remain very profitable...BUT ONLY IF SALES VOLUME IS INCREASED AND OVERHEAD IS REDUCED...It is obvious that in the hands of a BP, these goals would be achievable.

This would be especially true if the BP already had a sales force in the field, working on other drugs to reduce the incidence of CVD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News